MTRC released a seminar on reimbursement system for medical technologies in Luxembourg

10

Oct 2019

Luxembourg is a small country in a central Europe.

From the market access perspective, it has a relatively simple structure with hospitals being funding using a global budget principle, but physicians (in both hospital and out-patient settings) being reimbursed using a fee for service model. The inclusion of novel procedures into the Nomenclature of medical services represents the key challenge of market access for medical technologies in Luxembourg.

We offer a seminar on critical elements of the hospital and out-patient reimbursement system for medical devices in Luxembourg that can guide your decision-making about the introduction of novel technologies into this market.

The seminar discusses key stakeholders, money flow, reimbursement in hospital and ambulatory settings, Nomenclature of medical services, specifics of reimbursement processes and the role of HTA.

Learn more and request a quote here: https://www.a-marketaccess.com/luxembourg

The latest related news

22

Nov 2021

In August, MTRC launched two subscription services with a focus on all published, initiated or ongoing HTA and reimbursement reports and decisions for medical devices, procedures and IVD tests. HTA Alerts is a global service and covers 56 organizations from 24 countries. Reimbursement Alerts is focused on 14 key European countries. All alerts are tailed to the technologies of interest for each client. You can request a free-of-charge 2-month sample of reporting for both services

Read more

23

Sep 2021

In September 2021, MTRC received a certificate of conformity of the internal processes with the ISO 9001:2015 (quality management systems) standard. The certificate was issued by the United Kingdom Accreditation Service, UKAS. This confirms the commitment of the MTRC team to the provision of high-quality reimbursement services in Europe.

Read more

03

Aug 2021

A syndicated report (135 pages) reviews details of innovation funding and coverage with evidence development schemes in Europe, including Austria, Belgium, England, France, Germany, the Netherlands, and Switzerland. For each scheme, information about objective, inclusion criteria, applicant, stakeholders involved, clinical and economic evidence requirements, and statistics (including at least 2019-2020 data; but for most schemes – statistics for multiple years) is included.

Read more

12

Jul 2021

MTRC released an update of the syndicated report on reimbursement decisions for IVD tests in 5 EU countries (Belgium, France, Germany, the Netherlands, and Switzerland). The updated report covers 3-year period of 2018-2020. Broader coverage gives a better understanding of the activity of the reimbursement organizations.

Read more

17

May 2021

In August, MTRC launched two subscription services with a focus on all published, initiated or ongoing HTA and reimbursement reports and decisions for medical devices, procedures and IVD tests. HTA Alerts is a global service and covers 56 organizations from 24 countries. Reimbursement Alerts is focused on 14 key European countries. All alerts are tailed to the technologies of interest for each client. You can request a free-of-charge 2-month sample of reporting for both services

Read more